10 European Startups to watch in 2026 - European Biotechnology Magazine Ten young European biotechs are heading into 2026 with the kind of momentum that can quickly turn promising science into defining data: first clinical entries, platform-to-pipeline transitions, and fu...

Seamless Therapeutics is recognized as a top European biotech startup for 2026. Exciting to see our science making an impact!
#GeneEditing #Biotech #Innovation #SeamlessTherapeutics #ResearchImpact
european-biotechnology.com/background/1...

Privately held Seamless Therapeutics announced a global research and licensing agreement worth up to $1.12B with Eli Lilly to develop gene-editing treatments for hearing loss.

#LLYStock #EliLilly#GeneEditing #SeamlessTherapeutics #Biotech

Lilly allies with gene-editing firm Seamless on hearing loss Gene-editing firm Seamless Therapeutics has attracted its first major pharma partner, Eli Lilly, with a $1.12bn alliance focused on hearing loss

#Geneediting specialist #SeamlessTherapeutics has attracted its first major #pharmapartner, #EliLilly, with a $1.12 billion #alliance that will seek out therapies for #hearingloss.